176 related articles for article (PubMed ID: 25670199)
1. Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer.
Falchook AD; Hendrix LH; Chen RC
J Oncol Pract; 2015 Mar; 11(2):e239-46. PubMed ID: 25670199
[TBL] [Abstract][Full Text] [Related]
2. Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs.
Falchook AD; Salloum RG; Hendrix LH; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):243-8. PubMed ID: 24321784
[TBL] [Abstract][Full Text] [Related]
3. Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?
Grant Owens R; Loloi J; Lehman EB; Kaag MG; Raman JD; Merrill SB
Urol Oncol; 2021 Jul; 39(7):433.e9-433.e15. PubMed ID: 33610444
[TBL] [Abstract][Full Text] [Related]
4. Receipt of guideline-concordant treatment in elderly prostate cancer patients.
Chen RC; Carpenter WR; Hendrix LH; Bainbridge J; Wang AZ; Nielsen ME; Godley PA
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):332-8. PubMed ID: 24411605
[TBL] [Abstract][Full Text] [Related]
5. Imaging and evaluation of patients with high-risk prostate cancer.
Bjurlin MA; Rosenkrantz AB; Beltran LS; Raad RA; Taneja SS
Nat Rev Urol; 2015 Nov; 12(11):617-28. PubMed ID: 26481576
[TBL] [Abstract][Full Text] [Related]
6. General adherence to guideline recommendations on initial diagnosis of bladder cancer in the United States and influencing factors.
Karl A; Adejoro O; Saigal C; Konety B;
Clin Genitourin Cancer; 2014 Aug; 12(4):270-7. PubMed ID: 24332507
[TBL] [Abstract][Full Text] [Related]
7. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer.
Rutledge AB; McLeod N; Mehan N; Regan TW; Ainsworth P; Chong P; Doyle T; White M; Sanson-Fisher RW; Martin JM
BJU Int; 2018 May; 121 Suppl 3():22-27. PubMed ID: 29359883
[TBL] [Abstract][Full Text] [Related]
8. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
[TBL] [Abstract][Full Text] [Related]
9. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy.
Dowling JA; Lambert J; Parker J; Salvado O; Fripp J; Capp A; Wratten C; Denham JW; Greer PB
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e5-11. PubMed ID: 22330995
[TBL] [Abstract][Full Text] [Related]
10. [MRI. CT. bone scintigraphy].
Kaji Y
Hinyokika Kiyo; 2006 Jun; 52(6):507. PubMed ID: 16862732
[No Abstract] [Full Text] [Related]
11. Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone.
Wu SL; Jones E; Gulley JL; Arlen PM; Chen CC; Figg WD; Dahut WL
BJU Int; 2007 Mar; 99(3):525-8. PubMed ID: 17155971
[TBL] [Abstract][Full Text] [Related]
12. Indeterminate liver and renal lesions: comparison of computed tomography and magnetic resonance imaging in providing a definitive diagnosis and impact on recommendations for additional imaging.
Margolis NE; Shaver CM; Rosenkrantz AB
J Comput Assist Tomogr; 2013; 37(6):882-6. PubMed ID: 24270109
[TBL] [Abstract][Full Text] [Related]
13. Overutilization and Cost of Advanced Imaging for Long-Bone Cartilaginous Lesions.
Wilson RJ; Zumsteg JW; Hartley KA; Long JH; Mesko NW; Halpern JL; Schwartz HS; Holt GE
Ann Surg Oncol; 2015 Oct; 22(11):3466-73. PubMed ID: 25564171
[TBL] [Abstract][Full Text] [Related]
14. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis.
Albertsen PC; Hanley JA; Harlan LC; Gilliland FD; Hamilton A; Liff JM; Stanford JL; Stephenson RA
J Urol; 2000 Apr; 163(4):1138-43. PubMed ID: 10737483
[TBL] [Abstract][Full Text] [Related]
15. National audit of appropriate imaging.
Remedios D; Drinkwater K; Warwick R;
Clin Radiol; 2014 Oct; 69(10):1039-44. PubMed ID: 25037149
[TBL] [Abstract][Full Text] [Related]
16. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.
Prasad SM; Gu X; Lipsitz SR; Nguyen PL; Hu JC
Cancer; 2012 Mar; 118(5):1260-7. PubMed ID: 21823112
[TBL] [Abstract][Full Text] [Related]
17. Higher scrotal uptake ratio of (99m)Tc-MDP on bone scans in newly diagnosed prostate cancer: a reliable indicator of pelvic node metastasis.
Zaman MU; Fatima N; Sajjad Z; Hashmi I; Khan K
Ann Nucl Med; 2012 Oct; 26(8):676-80. PubMed ID: 22777858
[TBL] [Abstract][Full Text] [Related]
18. Health disparities and inequities in the utilization of diagnostic imaging for prostate cancer.
Washington C; Deville C
Abdom Radiol (NY); 2020 Dec; 45(12):4090-4096. PubMed ID: 32761404
[TBL] [Abstract][Full Text] [Related]
19. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CT and MRI scanning among cancer patients in Ontario.
Coburn N; Przybysz R; Barbera L; Hodgson DC; Laupacis A; Law C
Clin Imaging; 2011; 35(4):301-8. PubMed ID: 21724124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
